Landscapes / Companies
Price Vision Group not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 2 in all
Trials
2 active
6 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Riboflavin 0.1% ophthalmic solutionnot checked |
— |
Phase 2/3 | 31 Dec 2030Phase 2/3 trial completes | ||
| Next date | 31 Dec 2030 · Phase 2/3 trial completes | ||||
| Also tested for | Keratoconus, Corneal Ectasia | ||||
| Open drug page | |||||
About
- No active trial
- Netarsudil Ophthalmic
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021